215 related articles for article (PubMed ID: 8349790)
1. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.
Yang H; Rotter JI; Toyoda H; Landers C; Tyran D; McElree CK; Targan SR
J Clin Invest; 1993 Aug; 92(2):1080-4. PubMed ID: 8349790
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers.
Hirv K; Seyfarth M; Uibo R; Kull K; Salupere R; Latza U; Rink L
Scand J Gastroenterol; 1999 Oct; 34(10):1025-32. PubMed ID: 10563674
[TBL] [Abstract][Full Text] [Related]
3. Are HLA-DR or TAP genes genetic markers of severity in ulcerative colitis?
Heresbach D; Alizadeh M; Reumaux D; Colombel JF; Delamaire M; Danze PM; Gosselin M; Genetet B; Bretagne JF; Semana G
J Autoimmun; 1996 Dec; 9(6):777-84. PubMed ID: 9115580
[TBL] [Abstract][Full Text] [Related]
4. HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder.
Perri F; Annese V; Piepoli A; Napolitano G; Lombardi G; Ciavarella G; Di Giorgio G; Andriulli A
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):56-61. PubMed ID: 9615268
[TBL] [Abstract][Full Text] [Related]
5. Distinct associations of HLA class II genes with inflammatory bowel disease.
Toyoda H; Wang SJ; Yang HY; Redford A; Magalong D; Tyan D; McElree CK; Pressman SR; Shanahan F; Targan SR
Gastroenterology; 1993 Mar; 104(3):741-8. PubMed ID: 8440433
[TBL] [Abstract][Full Text] [Related]
6. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
[TBL] [Abstract][Full Text] [Related]
7. The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease.
Satsangi J; Landers CJ; Welsh KI; Koss K; Targan S; Jewell DP
Inflamm Bowel Dis; 1998 Feb; 4(1):18-26. PubMed ID: 9552224
[TBL] [Abstract][Full Text] [Related]
8. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP
Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450
[TBL] [Abstract][Full Text] [Related]
9. HLA antigens and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease.
García Herola A; Nos P; Hinijosa J; Hoyos M; Molés JR; Carmona E; Puig N; Sánchez-Cuenca JM; Ponce J; Berenguer J
Rev Esp Enferm Dig; 2003 Nov; 95(11):760-4, 755-9. PubMed ID: 14640873
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between HLA-DRB1 alleles of the major histocompatibility complex and p-ANCA status or clinical characteristics in patients with ulcerative colitis.
Folwaczny C; Zahn R; Brünnler G; Albert E; Koenig A; Noehl N; Loeschke K; Fricke H
Z Gastroenterol; 1999 Feb; 37(2):133-40. PubMed ID: 10190246
[TBL] [Abstract][Full Text] [Related]
11. Role of antineutrophil cytoplasmic antibodies in an ethnically distinct population: Korean patients with ulcerative colitis.
Kim WH; Choi PM; Landers CJ; Targan SR
Am J Gastroenterol; 1995 Nov; 90(11):1953-8. PubMed ID: 7484998
[TBL] [Abstract][Full Text] [Related]
12. Association of HLA class-II genes and anti-neutrophil cytoplasmic antibodies in Chinese patients with inflammatory bowel disease.
Lee YT; Sung JJ; Poon P; Lai KN; Li PK
Scand J Gastroenterol; 1998 Jun; 33(6):623-7. PubMed ID: 9669635
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory bowel disease: susceptibility and disease heterogeneity revealed by human leukocyte antigen genotyping.
Bouzid D; Kammoun A; Amouri A; Mahfoudh N; Haddouk S; Tahri N; Makni H; Masmoudi H
Genet Test Mol Biomarkers; 2012 Jun; 16(6):482-7. PubMed ID: 22224635
[TBL] [Abstract][Full Text] [Related]
14. Association of the HLA-DRB1*0701 allele with perinuclear anti-neutrophil cytoplasmatic antibodies in Mexican patients with severe ulcerative colitis.
Yamamoto-Furusho JK; Uscanga-Domínguez L; Lopez-Martinez A; Granados J
World J Gastroenterol; 2006 Mar; 12(10):1617-20. PubMed ID: 16570357
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome.
Dunphy J; Oliver M; Rands AL; Lovell CR; McHugh NJ
Br J Dermatol; 2000 Mar; 142(3):461-7. PubMed ID: 10735951
[TBL] [Abstract][Full Text] [Related]
16. Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD).
Bouma G; Oudkerk Pool M; Crusius JB; Schreuder GM; Hellemans HP; Meijer BU; Kostense PJ; Giphart MJ; Meuwissen SG; Peña AS
Clin Exp Immunol; 1997 Jul; 109(1):175-9. PubMed ID: 9218841
[TBL] [Abstract][Full Text] [Related]
17. HLA-DRB1*1502 confers susceptibility to ulcerative colitis, but is negatively associated with its intractability: a Korean study.
Myung SJ; Yang SK; Jung HY; Chang HS; Park B; Hong WS; Kim JH; Min I
Int J Colorectal Dis; 2002 Jul; 17(4):233-7. PubMed ID: 12073071
[TBL] [Abstract][Full Text] [Related]
18. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
[TBL] [Abstract][Full Text] [Related]
19. Genetic and immunological markers in pouchitis.
Brett PM; Yasuda N; Yiannakou JY; Herbst F; Ellis HJ; Vaughan R; Nicholls RJ; Ciclitira PJ
Eur J Gastroenterol Hepatol; 1996 Oct; 8(10):951-5. PubMed ID: 8930557
[TBL] [Abstract][Full Text] [Related]
20. Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup.
Duerr RH; Neigut DA
Gastroenterology; 1995 Feb; 108(2):423-7. PubMed ID: 7835583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
